Pro-Inflammatory Cytokine Glucocorticoid Resistance in Major Depressive Disorder

重度抑郁症中的促炎细胞因子糖皮质激素抵抗

基本信息

项目摘要

DESCRIPTION (provided by applicant): Major depressive disorder (MDD) is a worldwide public health problem, responsible for considerable disability, mortality, cost, and medical comorbidity. Psychosocial stressors have been linked with the onset, severity, and course of MDD and depressive symptoms. According to the stress-sensitization or kindling model of depression, the stress and depression association is dynamic, with more significant stressors triggering initial depressive episodes, and less significant stressors capable of triggering subsequent depressive episodes. While several pathophysiological mechanisms of stress sensitization have been proposed, including alterations in immune ("the cytokine model of depression") and hormonal responses to psychological stressors, it is possible that endocrine-immune interactions, specifically pro-inflammatory cytokine glucocorticoid resistance (GCR), underlie the stress and depression association. Thus, the purpose of this proposed study is to test a physiological explanation for the stress sensitization model of depression by examining cytokine responses to an acute psychological stressor and in vitro measures of pro-inflammatory cytokine GCR in 50 currently depressed and 50 never-depressed pre-menopausal women. The proposed study addresses whether depressed women, and particularly those with recurrent depression: 1) exhibit higher basal plasma levels of pro-inflammatory cytokines (i.e., II-1b, II-6, TNF-a), greater pro-inflammatory cytokine production in response to in vitro mitogen stimulation, and a more exaggerated pattern of pro-inflammatory cytokine responses to a Trier Social Stress Test than never-depressed controls, and 2) exhibit higher levels of basal in vitro lymphocyte pro-inflammatory cytokine GCR than never-depressed controls. This study will also address whether in vitro lymphocyte pro-inflammatory cytokine GCR is a prognostic indicator of likelihood of depression diagnosis 12 months later in depressed women. The proposed research study is designed to improve current understanding of the pathophysiology of major depressive disorder (MDD). Results of this study may lead to novel behavioral and/or pharmacological (e.g., anti-cytokine and/or anti-inflammatory agents) anti-depressant treatments for recurrent depression. Such treatments would not only benefit individuals with primary MDD, but may also extend to those with comorbid medical illnesses involving inflammatory processes (e.g., cardiovascular disease, coronary heart disease, rheumatoid arthritis, multiple sclerosis).
描述(由申请人提供):重度抑郁症 (MDD) 是一个世界性的公共卫生问题,造成相当大的残疾、死亡率、费用和医疗合并症。社会心理压力源与重度抑郁症和抑郁症状的发生、严重程度和病程有关。根据抑郁症的压力敏化或点燃模型,压力和抑郁的关联是动态的,较大的压力源会引发最初的抑郁发作,而较不显着的压力源则能够引发随后的抑郁发作。虽然已经提出了几种压力敏化的病理生理学机制,包括免疫的改变(“抑郁的细胞因子模型”)和对心理压力源的激素反应,但内分泌-免疫相互作用,特别是促炎细胞因子糖皮质激素抵抗(GCR),可能是压力和抑郁关联的基础。因此,本研究的目的是通过检查细胞因子对急性心理应激源的反应以及 50 名当前抑郁症和 50 名从未抑郁的绝经前女性的促炎细胞因子 GCR 的体外测量,来测试抑郁症压力敏化模型的生理学解释。拟议的研究探讨了抑郁女性,尤其是复发性抑郁女性是否:1)与从未抑郁的对照组相比,促炎细胞因子(即 II-1b、II-6、TNF-a)的基础血浆水平更高,体外促炎细胞因子刺激产生更多的促炎细胞因子,对特里尔社会压力测试的促炎细胞因子反应模式更夸张, 2) 与从未抑郁的对照组相比,体外基础淋巴细胞促炎细胞因子 GCR 的水平更高。这项研究还将探讨体外淋巴细胞促炎细胞因子 GCR 是否是抑郁症女性 12 个月后诊断抑郁症可能性的预后指标。拟议的研究旨在提高目前对重度抑郁症(MDD)病理生理学的理解。这项研究的结果可能会导致针对复发性抑郁症的新型行为和/或药理学(例如抗细胞因子和/或抗炎药)抗抑郁治疗。此类治疗不仅有益于患有原发性 MDD 的个体,而且还可能适用于那些患有涉及炎症过程的共存疾病(例如心血管疾病、冠心病、类风湿性关节炎、多发性硬化症)的患者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HEATHER M BURKE其他文献

HEATHER M BURKE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HEATHER M BURKE', 18)}}的其他基金

Pro-Inflammatory Cytokine Glucocorticoid Resistance in Major Depressive Disorder
重度抑郁症中的促炎细胞因子糖皮质激素抵抗
  • 批准号:
    7144248
  • 财政年份:
    2006
  • 资助金额:
    $ 17.18万
  • 项目类别:
Pro-Inflammatory Cytokine Glucocorticoid Resistance in Major Depressive Disorder
重度抑郁症中的促炎细胞因子糖皮质激素抵抗
  • 批准号:
    7907654
  • 财政年份:
    2006
  • 资助金额:
    $ 17.18万
  • 项目类别:
Pro-Inflammatory Cytokine Glucocorticoid Resistance in Major Depressive Disorder
重度抑郁症中的促炎细胞因子糖皮质激素抵抗
  • 批准号:
    7492123
  • 财政年份:
    2006
  • 资助金额:
    $ 17.18万
  • 项目类别:
Pro-Inflammatory Cytokine Glucocorticoid Resistance in Major Depressive Disorder
重度抑郁症中的促炎细胞因子糖皮质激素抵抗
  • 批准号:
    7288767
  • 财政年份:
    2006
  • 资助金额:
    $ 17.18万
  • 项目类别:
PREDOCTORAL FELLOWSHIP PROGRAM
博士前奖学金计划
  • 批准号:
    6509491
  • 财政年份:
    2002
  • 资助金额:
    $ 17.18万
  • 项目类别:
PREDOCTORAL FELLOWSHIP PROGRAM
博士前奖学金计划
  • 批准号:
    6371693
  • 财政年份:
    2001
  • 资助金额:
    $ 17.18万
  • 项目类别:
PREDOCTORAL FELLOWSHIP PROGRAM
博士前奖学金计划
  • 批准号:
    6168013
  • 财政年份:
    2000
  • 资助金额:
    $ 17.18万
  • 项目类别:
PREDOCTORAL FELLOWSHIP PROGRAM
博士前奖学金计划
  • 批准号:
    2908808
  • 财政年份:
    1999
  • 资助金额:
    $ 17.18万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 17.18万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.18万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 17.18万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.18万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 17.18万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.18万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 17.18万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 17.18万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 17.18万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.18万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了